AG-120
19-393
Phase 2 small_molecule active
Quick answer
AG-120 for Chondrosarcoma is a Phase 2 program (small_molecule) at AGIOS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AGIOS PHARMACEUTICALS, INC.
- Indication
- Chondrosarcoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active